Cyclosporine In Takotsubo Syndrome

A phase 2 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 204 participants.

Also called NCT05946772

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 204 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05946772
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Germany (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05946772. Randomized; quadruple masking; primary purpose treatment. Start 2025-02-01 (actual); primary completion 2027-02 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Cyclosporine In Takotsubo Syndrome
Acronym
CIT
Condition
Takotsubo Cardiomyopathy
Intervention (Drug)
Cyclosporine A
Intervention (Drug)
Placebo
Lead sponsor
University Hospital Heidelberg (class: other)
Collaborator
German Centre of Cardiovascular Research (DZHK) (class: not stated)
Collaborator
Coordinating Centre for Clinical Studies (KKS) Heidelberg (class: not stated)

Record details

Record id
cardio:ct-nct05946772
Content hash
3598454fb305ed53571c4e5fedaebf2343bb4d2fa56a65be27fba3a58482e1cc